This method to reverse cellular aging is about to be tested in humans

image via New Scientist

April 13, 2026, 10:30 AM

• •Partial reprogramming uses Yamanaka factors to revert cells to a younger state.
• •The clinical trial will test this approach in humans with retinal nerve damage.
• •Risks include the potential for cells to become cancerous or lose function.
• •Significant investment has been made in this field by both academics and tech industry leaders.
• •Different approaches are being tested, including using alternative genes and chemicals.

A clinical trial is set to begin that will test the safety of a method to reverse cellular aging in humans. The method involves partially reprogramming cells to a younger state using Yamanaka factors. This burgeoning field has drawn significant investment and attention, sparking both excitement and concern about the potential to reshape the concept of aging and rejuvenate organs. Risks include potential loss of cell function or cancer, while the trial aims to assess safety and efficacy in treating age-related retinal nerve damage.

Read original article